Regenxbio
RGNX
RGNX
108 hedge funds and large institutions have $718M invested in Regenxbio in 2017 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 30 increasing their positions, 34 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.14% more ownership
Funds ownership: 69.15% → 69.29% (+0.14%)
12% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 34
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
108
Holding in Top 10
1
Calls
$13.1M
Puts
$6.3M
Top Buyers
| 1 | +$25.6M | |
| 2 | +$12.6M | |
| 3 | +$9.29M | |
| 4 |
DM
Deerfield Management
New York
|
+$8.52M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$8.48M |
Top Sellers
| 1 | -$23.9M | |
| 2 | -$23.8M | |
| 3 | -$13.8M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$13.7M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$8.06M |